A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study
Condition: Priapism Due to Sickle Cell Disease Interventions: Drug: Tadalafil; Drug: Hydroxyurea; Drug: Placebo Sponsor: Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2021 Category: Research Source Type: clinical trials